Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiling Chen

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Hepatology (Baltimore, Md.)|February 17, 2023
P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseasesJun Zhang, Zhuwan Lyu, Bo Li, et al.
Hepatology (Baltimore, Md.)|February 8, 2021
The Clinical Significance of Hepatic CD69<sup>+</sup> CD103<sup>+</sup> CD8<sup>+</sup> Resident-Memory T Cells in Autoimmune HepatitisZhengrui You, You Li, Qixia Wang, et al.
Gastroenterology|May 29, 2024
Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary CholangitisRui Wang, Bo Li, Bingyuan Huang, et al.
Clinical Reviews in Allergy & Immunology|June 3, 2022
Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the LiteratureMingli Hu, Zhengrui You, You Li, et al.
Med (New York, N.Y.)|September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitisQiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.
Journal of Hepatology|June 26, 2022
NUDT1 promotes the accumulation and longevity of CD103<sup>+</sup> T<sub>RM</sub> cells in primary biliary cholangitisBingyuan Huang, Zhuwan Lyu, Qiwei Qian, et al.
Hepatology Communications|December 11, 2021
MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T CellsYong Chen, Xiangwei Hua, Bingyuan Huang, et al.
Gut|May 26, 2021
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitisQiaoyan Liu, Bo Li, Yikang Li, et al.
Nature Communications|March 28, 2023
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expressionYou Li, Zhiqiang Li, Ruiling Chen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Hepatology (Baltimore, Md.)|February 17, 2023
P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseasesJun Zhang, Zhuwan Lyu, Bo Li, et al.
Hepatology (Baltimore, Md.)|February 8, 2021
The Clinical Significance of Hepatic CD69<sup>+</sup> CD103<sup>+</sup> CD8<sup>+</sup> Resident-Memory T Cells in Autoimmune HepatitisZhengrui You, You Li, Qixia Wang, et al.
Gastroenterology|May 29, 2024
Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary CholangitisRui Wang, Bo Li, Bingyuan Huang, et al.
Clinical Reviews in Allergy & Immunology|June 3, 2022
Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the LiteratureMingli Hu, Zhengrui You, You Li, et al.
Med (New York, N.Y.)|September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitisQiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.
Journal of Hepatology|June 26, 2022
NUDT1 promotes the accumulation and longevity of CD103<sup>+</sup> T<sub>RM</sub> cells in primary biliary cholangitisBingyuan Huang, Zhuwan Lyu, Qiwei Qian, et al.
Hepatology Communications|December 11, 2021
MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T CellsYong Chen, Xiangwei Hua, Bingyuan Huang, et al.
Gut|May 26, 2021
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitisQiaoyan Liu, Bo Li, Yikang Li, et al.
Nature Communications|March 28, 2023
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expressionYou Li, Zhiqiang Li, Ruiling Chen, et al.
Pageof 3